Please ensure Javascript is enabled for purposes of website accessibility

Nevada receives $29.8M in multi-state settlement with opioid manufacturer


Hydrocodone pills, a type of opioid, are pictured in this file image. (Photo: U.S. Drug Enforcement Administration)
Hydrocodone pills, a type of opioid, are pictured in this file image. (Photo: U.S. Drug Enforcement Administration)
Facebook Share IconTwitter Share IconEmail Share Icon

Nevada will receive nearly $29.8 million after joining a multi-state settlement with the opioid manufacturer Allergan.

Attorney General Aaron Ford's office announced the settlement on Wednesday after alleging Allergan violated the state's deceptive trade practices law by failing to regulate prescription opioids properly.

"Settlement recoveries, including these funds, are a vital component to combatting the opioid epidemic in our state," Ford said in a statement. "The recoveries will fund programs and services throughout the state to help eradicate this epidemic and help Nevadans affected by the opioid epidemic."

MORE ON NEWS 3 |Narcan approval praised by anti-opioid advocates

Of the settlement funds, $26.5 million will go towards remediation, paid over a seven-year period. The remainder will serve as a credit for attorneys' fees.

Allergan's parent company, AbbVie, announced it had agreed to a nationwide settlement back in November to resolve opioid-related claims.

The Nevada Legislature in 2021 created the Fund for a Resilient Nevada, which directs state opioid recoveries to fund programs in the Department of Health and Human Services.

Loading ...